Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical study of ALRN-6924 in healthy volunteers

Trial Profile

Clinical study of ALRN-6924 in healthy volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 02 Dec 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ALRN 6924 (Primary)
  • Indications Breast cancer; Chemotherapy-induced damage; Haematological malignancies; Radiation injuries; Solid tumours
  • Focus Adverse reactions
  • Sponsors Aileron Therapeutics
  • Most Recent Events

    • 28 Oct 2022 Results (As of June 20, 2022, n=42 )presented at the 34th EORTC-NCI-AACR Symposium on molecular targets and cancer therapeutics
    • 26 Oct 2022 Results published in the Media Release
    • 26 Oct 2022 According to an Aileron Therapeutics media release, data from this study presented at the EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics 2022
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top